03:10 PM EDT, 05/27/2026 (MT Newswires) -- Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index up 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.2%.

The iShares Biotechnology ETF (IBB) added 0.6%.

In corporate news, BioNTech's (BNTX) cancer-drug pipeline is showing stronger early results and is approaching several important clinical milestones, improving confidence in the company's long-term outlook, UBS Securities said in a report. UBS upgraded its rating on BioNTech stock to buy from neutral and raised its price target to $135 from $117. BioNTech shares rose 1.2%.